Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Jul 27;176:113896. doi: 10.1016/j.addr.2021.113896

Figure 1.

Figure 1.

Diagram highlighting the main types of immunomodulators. Immunosuppressants (left) including vaccines, antibodies, cytokines, and cell-based therapies have been used to exogenously activate the immune system for treatment of diseases such as cancer. Immunosuppressants (right) including antibodies, cytokines, NSAIDs, glucocorticoids, DMARDs, and cell-based therapies have been used to repress overly active immune systems for treatment of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, irritable bowel disease, systemic lupus erythematosus, and more. Schematic was made using BioRender.com